MedPath

上海新华联制药有限公司

Ownership
-
Established
2010-11-24
Employees
-
Market Cap
-
Website
http://www.nhl-pharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

替加氟

Approval Number
国药准字H31021821
Approval Date
Sep 2, 2024
NMPA

米非司酮

Approval Number
国药准字H10950131
Approval Date
Jul 22, 2024
NMPA

碘解磷定

Approval Number
国药准字H31020156
Approval Date
Jan 30, 2024
NMPA

维生素D3

Approval Number
国药准字H31020081
Approval Date
Aug 19, 2020
NMPA

丙酸氯倍他索

Approval Number
国药准字H31020354
Approval Date
Aug 13, 2020
NMPA

醋酸地塞米松

Approval Number
国药准字H31021586
Approval Date
Aug 13, 2020
NMPA

醋酸甲羟孕酮

Approval Number
国药准字H31021623
Approval Date
Aug 11, 2020
NMPA

醋酸甲地孕酮

Approval Number
国药准字H31021622
Approval Date
Aug 11, 2020
NMPA

泛影酸

Approval Number
国药准字H31020171
Approval Date
Jul 22, 2020
NMPA

异维A酸

Approval Number
国药准字H10930090
Approval Date
Jul 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.